Q BioMed Announces 2nd Closing on Funding and Advances Cancer Palliation Drug

COMPANY GEARS UP FOR PRODUCTION OF CANCER PAIN PALLIATION DRUG WITH COMMERCIAL LAUNCH EXPECTED IN Q2 2017   NEW YORK, March 22, 2017 — Q BioMed Inc. (OTCQB: QBIO), has closed on its 2nd tranche of the $4,000,000 funding announced on November 30th 2016. The company received $1,000,000 on the 2nd closing bringing the total […]

Read More

Q BIOMED JOINS WITH OKLAHOMA MEDICAL RESEARCH FOUNDATION AND RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY TO DEVELOP LIVER CANCER CHEMOTHERAPEUTIC

NEW YORK, February 7, 2017 – Q BioMed, Inc. (OTCQB: QBIO) has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB) to develop a chemotherapeutic technology to treat liver cancer.   The technology will utilize “uttroside B” and the compound’s derivatives as a chemotherapeutic agent […]

Read More

Q BioMed Inc. Announces Mannin Research Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto

NEW YORK, February 2, 2017  — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that Mannin Research, its research partner for the development of a novel pharmaceutical eye-drop to treat Primary Open-Angle Glaucoma utilizing the Tie2 Mechanism of Action, has been accepted into Johnson & Johnson Innovation, JLABS @ Toronto. […]

Read More

Q BIOMED INC. TECHNOLOGY PARTNER MANNIN RESEARCH INC. TO PARTICIPATE IN A WEBCAST ON INNOVATING FOR OPHTHALMIC DISEASES

Q BIOMED INC. Technology Partner Mannin Research Inc. to participate in a webcast on innovating for ophthalmic diseases Webcast, part of the Nature.Com BioPharma Dealmakers series, is scheduled for 10:00 am ET on October 20th. NEW YORK, October 19, 2016 — Q BioMed Inc. (OTCQB: QBIO), technology partner Mannin Research Inc. will present in a […]

Read More

Q BIOMED DRUG DEVELOPMENT PARTNER TO ATTEND EANM 2016 in BARCELONA, SPAIN October 15-19 2016

Q BIOMED DRUG DEVELOPMENT PARTNER TO ATTEND EANM 2016 in BARCELONA, SPAIN October 15-19 2016 Annual European Association Nuclear Medicine Congress Most Valuable Meeting World Wide NEW YORK, October 18, 2016 — Q BioMed Inc. (OTCQB: QBIO), drug development partner will attend the European Association of Nuclear Medicine (EANM) meeting in Barcelona, Spain. With more […]

Read More

Q BIOMED PARTNER MANNIN RESEARCH EXECUTIVES ATTENDING OIS@AAO 2016 & AAO

Q BIOMED PARTNER MANNIN RESEARCH EXECUTIVES ATTENDING OIS@AAO 2016 & AAO Ophthalmology Summits Attract Broad Range of Industry Professionals NEW YORK, October 13, 2016 — Q BioMed Inc. (OTCQB: QBIO), technology partner Mannin Research Inc will participate at the the Ophthalmology Innovation Summit  and the American Academy of Ophthalmology Annual Meeting in Chicago IL. Mannin […]

Read More
Social media & sharing icons powered by UltimatelySocial